123 related articles for article (PubMed ID: 18350204)
1. Prevalence of drug-drug interactions of antiretroviral agents in the private health care sector in South Africa.
Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
S Afr Med J; 2008 Feb; 98(2):109-13. PubMed ID: 18350204
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa.
Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
J Clin Pharm Ther; 2008 Aug; 33(4):393-400. PubMed ID: 18613857
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential drug-drug interactions between antiretroviral drugs from prescriptions in the private health-care sector in South Africa.
Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
Int J STD AIDS; 2012 Mar; 23(3):166-72. PubMed ID: 22581868
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
[TBL] [Abstract][Full Text] [Related]
5. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications.
Priyanka PSSL; Varma DM; Immadisetti K; Rajesh R; Vidyasagar S; Guddattu V
Int J Risk Saf Med; 2017; 29(1-2):25-55. PubMed ID: 28885219
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable.
Seden K; Back D; Khoo S
J Antimicrob Chemother; 2009 Jul; 64(1):5-8. PubMed ID: 19398457
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of potentially serious drug-drug interactions among South African elderly private health sector patients using the Mimica Matanović/Vlahović-Palčevski protocol.
van Heerden JA; Burger JR; Gerber JJ; Vlahović-Palčevski V
Int J Pharm Pract; 2018 Apr; 26(2):156-164. PubMed ID: 28665037
[TBL] [Abstract][Full Text] [Related]
8. Antiretrovial (ARV) drug utilisation in Harare.
Nyazema NZ; Khoza S; Landman I; Sibanda E; Gael K
Cent Afr J Med; 2000 Apr; 46(4):89-93. PubMed ID: 11210341
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
Gagne JJ; Maio V; Rabinowitz C
J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and management of drug-drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study.
Schlaeppi C; Vanobberghen F; Sikalengo G; Glass TR; Ndege RC; Foe G; Kuemmerle A; Paris DH; Battegay M; Marzolini C; Weisser M;
HIV Med; 2020 Jan; 21(1):53-63. PubMed ID: 31532898
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and type of drug-drug interactions involving ART in patients attending a specialist HIV outpatient clinic in Kampala, Uganda.
Seden K; Merry C; Hewson R; Siccardi M; Lamorde M; Byakika-Kibwika P; Laker E; Parkes-Ratanshi R; Back DJ; Khoo SH
J Antimicrob Chemother; 2015 Dec; 70(12):3317-22. PubMed ID: 26286575
[TBL] [Abstract][Full Text] [Related]
12. The intersection of drug interactions and adverse reactions in contemporary antiretroviral therapy.
Nhean S; Tseng A; Back D
Curr Opin HIV AIDS; 2021 Nov; 16(6):292-302. PubMed ID: 34459470
[TBL] [Abstract][Full Text] [Related]
13. Symptoms experienced by HIV-infected Individuals on antiretroviral therapy in KwaZulu-Natal, South Africa.
Bhengu BR; Ncama BP; McInerney PA; Wantland DJ; Nicholas PK; Corless IB; McGibbon CA; Davis SM; Nicholas TP; Ros AV
Appl Nurs Res; 2011 Feb; 24(1):1-9. PubMed ID: 20974052
[TBL] [Abstract][Full Text] [Related]
14. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients.
Tseng A; Szadkowski L; Walmsley S; Salit I; Raboud J
Ann Pharmacother; 2013 Nov; 47(11):1429-39. PubMed ID: 24285760
[TBL] [Abstract][Full Text] [Related]
15. The social construction of ARVs in South Africa.
Sember R
Glob Public Health; 2008; 3 Suppl 2():58-75. PubMed ID: 19288353
[TBL] [Abstract][Full Text] [Related]
16. Drug-Drug Interactions in People Living With HIV at Risk of Hepatic and Renal Impairment: Current Status and Future Perspectives.
Cottura N; Kinvig H; Grañana-Castillo S; Wood A; Siccardi M
J Clin Pharmacol; 2022 Jul; 62(7):835-846. PubMed ID: 34990024
[TBL] [Abstract][Full Text] [Related]
17. Interactions of antiretroviral drugs with anti-infectives and other antiretrovirals.
Pontali E
Chemotherapy; 2007; 53(1):26-9. PubMed ID: 17192710
[TBL] [Abstract][Full Text] [Related]
18. Use of comedications and potential drug-drug interactions in people living with HIV in China.
Chen R; Chen J; Tang Q; Meng Z; Luo L; Zhang W; Deng A; Zhang L; Wang J; Qi T; Zhang R; Shen Y; Liu L; Steinhart C; Lu H
J Infect Chemother; 2020 Jul; 26(7):722-728. PubMed ID: 32354599
[TBL] [Abstract][Full Text] [Related]
19. Potential drug-drug interactions with phentermine among long-term phentermine consumers: A retrospective analysis.
Fourie A; Julyan M; Mostert L; Du Plessis JM
S Afr Med J; 2023 Aug; 113(8):63-68. PubMed ID: 37882119
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications.
Stader F; Kinvig H; Battegay M; Khoo S; Owen A; Siccardi M; Marzolini C
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
